Loss of lean body mass ( LBM ) is a common occurrence after treatment for breast cancer and is related to deleterious metabolic health outcomes [ Clin Oncol , 22 ( 4 ) :281 -288 , 2010 ; Appl Physiol Nutr Metab , 34 ( 5 ) :950 -956 , 2009 ] .